https://www.danafarberplga.org/37/2014-03-27T18:48:06+00:00https://www.danafarberplga.org/108/2014-07-29T17:53:46+00:00https://www.danafarberplga.org/long-term-outcome-of-4040-children-diagnosed-with-pediatric-low-grade-gliomas-an-analysis-of-the-surveillance-epidemiology-and-end-results-seer-database-pediatric-blood-and-cancer/2014-05-14T12:53:30+00:00https://www.danafarberplga.org/casty-family-award-for-achievement-in-mentoring-2014/2014-04-17T19:41:54+00:00https://www.danafarberplga.org/plga-foundation-sponsored-seminar-5th-may-2014-dr-mark-kieran-long-term-survivorship-outcomes-for-children-battling-low-grade-glioma-brain-tumors/2014-05-14T12:50:28+00:00https://www.danafarberplga.org/2nd-annual-old-manlady-softball-game-to-benefit-the-plga-program-at-dana-farber-cancer-institute/2014-04-29T13:38:23+00:00https://www.danafarberplga.org/pediatric-low-grade-gliomas-how-modern-biology-reshapes-the-clinical-field/2014-05-14T12:41:52+00:00https://www.danafarberplga.org/dr-rosalind-segal-appointed-as-the-new-director-of-the-program-in-neuroscience-at-harvard-medical-school/2014-07-29T17:51:22+00:00https://www.danafarberplga.org/targeting-braf-in-pediatric-brain-tumors/2014-06-02T13:20:59+00:00https://www.danafarberplga.org/targeted-treatment-for-sonic-hedgehog-dependent-medulloblastoma/2014-06-30T15:17:52+00:00https://www.danafarberplga.org/recurrance-after-gross-total-resection-of-low-grade-pediatric-brain-tumors-the-frequence-and-timing-of-postoperative-imaging/2014-07-31T15:41:31+00:00https://www.danafarberplga.org/final-results-of-a-prospective-multi-institutional-phase-ii-study-of-everolimus-rad001-an-mtor-inhibitor-in-pediatric-patients-with-recurrent-or-progressive-low-grade-glioma-a-poetic-consortium-t/2014-09-02T16:53:45+00:00https://www.danafarberplga.org/successful-treatment-of-a-progressive-braf-v600e-mutated-anaplastic-pleomorphic-xanthoastrocytoma-with-vemurafenib-monotherapy/2014-10-01T13:04:48+00:00https://www.danafarberplga.org/time-to-rethink-the-unthinkable-upfront-biopsy-of-children-with-newly-diasnosed-diffuse-intrinsic-pontinr-glioma-dipg/2014-11-03T14:27:45+00:00https://www.danafarberplga.org/development-of-covalent-inhibitors-that-can-overcome-resistance-to-first-generation-fgfr-kinase-inhibitors/2014-12-01T14:28:55+00:00https://www.danafarberplga.org/preparing-for-our-annual-scientific-advisory-board-meeting-and-poster-session/2015-01-26T19:15:11+00:00https://www.danafarberplga.org/braf-mutation-and-cdkn2a-deletion-define-a-clinically-distinct-subgroup-of-childhood-secondary-high-grade-glioma/2015-03-02T14:47:15+00:00https://www.danafarberplga.org/dana-farber-lab-rats-are-joining-geared-up-for-kids-2015/2015-06-23T14:46:26+00:00https://www.danafarberplga.org/expression-profiles-of-151-pediatric-low-grade-gliomas-reveal-molecular-differences-associated-with-location-and-histological-subtype/2015-04-01T14:56:56+00:00https://www.danafarberplga.org/molecular-typing-of-meningiomas-by-desorption-electrospray-ionization-mass-spectrometry-imaging-for-surgical-decision-making/2015-05-01T14:22:21+00:00https://www.danafarberplga.org/pediatric-brainstem-gliomas-new-understanding-leads-to-potential-new-treatments-for-two-very-different-tumors/2015-05-28T12:49:19+00:00https://www.danafarberplga.org/dr-walensky-received-the-2015-e-mead-johnson-award-for-research-in-pediatrics/2018-12-07T00:06:24+00:00https://www.danafarberplga.org/future-clinical-trials-in-dipg-bringing-epigenetics-to-the-clinic/2015-08-03T15:36:34+00:00https://www.danafarberplga.org/maldi-mass-spectrometry-imaging-analysis-of-pituitary-adenomas-for-near-real-time-tumor-delineation/2015-09-02T12:29:58+00:00https://www.danafarberplga.org/genomic-characterization-of-brain-metastases-reveals-branched-evolution-and-potential-therapeutic-targets/2015-10-01T12:19:00+00:00https://www.danafarberplga.org/540-2/2018-12-07T00:06:10+00:00https://www.danafarberplga.org/myxopapillary-ependymomas-in-children-imaging-treatment-and-outcomes/2015-11-02T14:19:44+00:00https://www.danafarberplga.org/watch-dr-loren-walensky-talk-about-the-collaborative-drug-discovery-taking-place-at-dana-farber-cancer-institute/2018-12-07T00:04:45+00:00https://www.danafarberplga.org/a-brain-tumororganotypic-slice-co-culture-system-for-studying-tumor-microenvironment-and-targeted-drug-therapies/2015-12-01T14:43:56+00:00https://www.danafarberplga.org/myb-qki-rearrangements-in-angiocentric-glioma-drive-tumorigenicity-through-a-tripartite-mechanism/2016-02-02T14:03:18+00:00https://www.danafarberplga.org/clinical-and-treatment-factors-determining-long-term-outcomes-for-adult-survivors-of-childhood-low-grade-glioma-a-population-based-study/2016-04-05T17:38:57+00:00https://www.danafarberplga.org/spatial-and-temporal-homogeneity-of-driver-mutations-in-diffuse-intrinsic-pontine-glioma/2016-05-03T16:40:18+00:00https://www.danafarberplga.org/dfci-lab-rats-are-geared-up-for-kids/2018-12-07T00:02:58+00:00https://www.danafarberplga.org/characterizing-genomic-alterations-in-cancer-by-complementary-functional-associations/2016-12-29T21:34:55+00:00https://www.danafarberplga.org/brainstem-angiocentric-gliomas-with-myb-qki-rearrangements/2018-12-07T00:01:33+00:00https://www.danafarberplga.org/geared-up-for-kids-2018/2018-12-07T00:00:16+00:00https://www.danafarberplga.org/dana-farber-helps-flip-the-switch-with-the-pediatric-brain-tumor-foundation/2019-01-08T22:25:23+00:00https://www.danafarberplga.org/management-of-pediatric-low-grade-glioma/2026-04-22T17:49:29+00:00https://www.danafarberplga.org/mitogenic-and-progenitor-gene-programmes-in-single-pilocytic-astrocytoma-cells/2019-08-21T19:57:20+00:00https://www.danafarberplga.org/architecture-of-autoinhibited-and-active-braf-mek1-14-3-3-complexes/2020-03-26T16:55:46+00:00https://www.danafarberplga.org/tumor-micro-environment/2026-04-22T18:23:50+00:00https://www.danafarberplga.org/john-mimi-amy/2020-05-11T17:27:47+00:00https://www.danafarberplga.org/pediatric-low-grade-astrocytomas-plgas-need-research/2026-04-22T17:48:00+00:00https://www.danafarberplga.org/congratulations-daphne-being-elected-to-the-national-academy-of-medicine/2020-05-11T17:15:06+00:00https://www.danafarberplga.org/plga-appreciation/2026-04-22T17:48:41+00:00https://www.danafarberplga.org/genomics/2020-05-11T17:22:59+00:00https://www.danafarberplga.org/drug-development/2020-05-11T17:22:43+00:00https://www.danafarberplga.org/clinical-trials-and-tissue-banking-2/2020-05-11T17:40:56+00:00https://www.danafarberplga.org/roz-segal-honored-for-advancing-womens-careers-2/2020-05-11T17:29:50+00:00https://www.danafarberplga.org/team-nathan-pmc-riders-lab-visit-and-check-presentation/2020-05-11T17:31:53+00:00https://www.danafarberplga.org/pmc-teams-visit-june-12-2019-2/2020-05-11T17:42:36+00:00https://www.danafarberplga.org/welcome-bill-kimberly-and-john-2/2020-05-11T17:45:34+00:00https://www.danafarberplga.org/gearupshowupcare/2020-05-28T17:38:11+00:00https://www.danafarberplga.org/day-one-announces-preliminary-phase-1-results-for-day101-in-pediatric-low-grade-glioma-receipt-of-breakthrough-therapy-designation-btd-and-new-phase-2-study/2020-11-19T23:53:12+00:00https://www.danafarberplga.org/advances-in-the-classification-and-treatment-of-pediatric-brain-tumors/2026-04-22T20:21:14+00:00